Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Not applicableLooking for participantsNCT06952400What this trial is testingThe Registry Study of Genetic Alterations of Melanoma in TaiwanWho this might be right forPrimary Melanoma of the Extremity National Health Research Institutes, Taiwan 250
Testing effectiveness (Phase 2)Study completedNCT01100528What this trial is testingDacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic ImbalanceWho this might be right forCiliary Body and Choroid Melanoma, Medium/Large SizeCiliary Body and Choroid Melanoma, Small SizeIris Melanoma+1 more Case Comprehensive Cancer Center 38
Large-scale testing (Phase 3)UnknownNCT01502696What this trial is testingAdjuvant PEG Intron in Ulcerated MelanomaWho this might be right forUlcerated Melanomas European Organisation for Research and Treatment of Cancer - EORTC 1,200
Not applicableStudy completedNCT01624220What this trial is testingA Prospective Study Using Implanted Fiducial Markers to Assess Treatment Accuracy and Esophageal Toxicity in Spinal Stereotactic Body Radiation TherapyWho this might be right forSpinal Tumor M.D. Anderson Cancer Center 41
Not applicableStudy completedNCT07429123What this trial is testingUsing an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health CentersWho this might be right forSkin ConditionSkin AbnormalitiesMalignancy+2 more AI Labs Group S.L 131
Not applicableStudy completedNCT05172232What this trial is testingDiagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous LesionsWho this might be right forMalignant Melanoma Linkoeping University 231
Large-scale testing (Phase 3)UnknownNCT00005052What this trial is testingVaccine Therapy in Treating Patients With Primary Stage II MelanomaWho this might be right forMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Study completedNCT03033576What this trial is testingTesting Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Melanoma of Unknown Primary+3 more National Cancer Institute (NCI) 94
Testing effectiveness (Phase 2)Study completedNCT03052127What this trial is testingStudy in Subjects With Small Primary Choroidal MelanomaWho this might be right forUveal MelanomaOcular MelanomaChoroidal Melanoma Aura Biosciences 57
Large-scale testing (Phase 3)Ended earlyNCT00036816What this trial is testingVaccine Therapy in Treating Patients With Melanoma of the EyeWho this might be right forIntraocular Melanoma European Organisation for Research and Treatment of Cancer - EORTC 13
Early research (Phase 1)Active Not RecruitingNCT03872947What this trial is testingTRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid TumorsWho this might be right forSolid TumorColorectal CancerCholangiocarcinoma+9 more Toray Industries, Inc 138
Early research (Phase 1)Ended earlyNCT05831995What this trial is testingSafety and Effectiveness of ABM-168 in Adults with Advanced Solid Tumors.Who this might be right forAdvanced Solid TumorRAS MutationRAF Mutation+1 more ABM Therapeutics Corporation 12
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Not applicableLooking for participantsNCT07407166What this trial is testingEfficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive BiomarkersWho this might be right forMetastatic MelanomaMelanoma Institute of Oncology Ljubljana 40
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Study completedNCT00089362What this trial is testingAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsWho this might be right forMale Breast CancerRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+73 more National Cancer Institute (NCI) 30
Not applicableLooking for participantsNCT03702309What this trial is testingLiquid Biopsy Evaluation and Repository Development at Princess MargaretWho this might be right forCancerBreast CancerLung Cancer+15 more University Health Network, Toronto 2,500
Testing effectiveness (Phase 2)UnknownNCT00553618What this trial is testingAdjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma PatientsWho this might be right forMetastatic Melanoma University of Louisville 160
Not applicableStudy completedNCT07757386What this trial is testingMelaMEd Online Training for General Practitioners to Improve Melanoma Detection and ManagementWho this might be right forCutaneous Melanoma Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,531